Tobias Böttcher

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study

Arndt Rolfs, Tobias Böttcher, Marlies Zschiesche et al. · The Lancet · 2005 · 467 citations

Medicine, Clinical Sciences, Neurology +5

Apheresis therapies for NMOSD attacks

Ingo Kleiter, Anna Gahlen, Nadja Borisow et al. · Neurology Neuroimmunology & Neuroinflammation · 2018 · 231 citations · Full text

Life Sciences, Immunology, Neurology +13

Acute Cerebrovascular Disease in the Young

Arndt Rolfs, Franz Fazekas, Ulrike Grittner et al. · Stroke · 2013 · 212 citations · Full text

Medicine, Clinical Sciences, Neurology +12

Glucosylsphingosine Is a Highly Sensitive and Specific Biomarker for Primary Diagnostic and Follow-Up Monitoring in Gaucher Disease in a Non-Jewish, Caucasian Cohort of Gaucher Disease Patients

Arndt Rolfs, Anne‐Katrin Giese, Ulrike Grittner et al. · PLoS ONE · 2013 · 194 citations · Full text

Life Sciences, Biochemistry, Pathology +17

Reduced Release of Pneumolysin by <i>Streptococcus pneumoniae</i> In Vitro and In Vivo after Treatment with Nonbacteriolytic Antibiotics in Comparison to Ceftriaxone

Annette Spreer, Holger Kerstan, Tobias Böttcher et al. · Antimicrobial Agents and Chemotherapy · 2003 · 106 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13